Review of recent preclinical and clinical research on ligand-targeted liposomes as delivery systems in triple negative breast cancer therapy

M Hajimolaali, FA Dorkoosh… - Journal of Liposome …, 2024 - Taylor & Francis
Triple-negative breast Cancer (TNBC) is one of the deadliest types, making up about 20% of
all breast cancers. Chemotherapy is the traditional manner of progressed TNBC treatment; …

In vivo evaluation of mebendazole and Ran GTPase inhibition in breast cancer model system

B Abu-Hdaib, H Nsairat, M El-Tanani, I Al-Deeb… - …, 2024 - Taylor & Francis
Aim: To investigate the therapeutic potential of mebendazole (MBZ)-loaded nanostructured
lipid carriers (NLCs). Methodology: NLC-MBZ was prepared and characterized to evaluate …